Patents Represented by Attorney Margaret Horn
  • Patent number: 5275821
    Abstract: There are provided, novel no or low wax formulations for amantadine hydrochloride and methods for preparing such formulations.
    Type: Grant
    Filed: June 5, 1992
    Date of Patent: January 4, 1994
    Assignee: The Du Pont Merck Pharmaceutical Company
    Inventor: George Torosian
  • Patent number: 5243048
    Abstract: There are provided cycloalkyl piperidine compounds which are useful in the treatment of physiological or drug-induced psychosis or dyskinesia in a mammal. These novel compounds are selective sigma receptor antagonists and have a low potential for movement disorder side effects associated with typical antipsychotic agents.
    Type: Grant
    Filed: February 6, 1992
    Date of Patent: September 7, 1993
    Assignee: The Du Pont Merck Pharmaceutical Company
    Inventors: Gary A. Cain, Paul J. Gilligan, Sang W. Tam
  • Patent number: 5139946
    Abstract: There is disclosed a perfusable cell culture device capable of expansion and maintenance of biological cells, including mammalian, microbial, plant and insect cells in culture. The device comprises an upper and lower polymeric film layer and a gas and liquid permeable flow divider membrane. The flow divider membrane is affixed between the upper and lower polymeric layers and to the lower polymeric layer in a manner providing channels for fluid distribution of culture medium which is perfused at a controlled rate, uniformly across the flow divider membrane and to a bed of cells dispersed on the flow divider membrane.
    Type: Grant
    Filed: July 9, 1991
    Date of Patent: August 18, 1992
    Assignee: Du Pont Merck Pharmaceutical Company
    Inventors: Gary W. Howell, Joseph D. Irr, Ara T. Nahapetian
  • Patent number: 5135934
    Abstract: Dihydrobenz[c]acridine carboxylic acid derivatives are provided which are useful for the treatment and/or prevention of organ transplantation rejection, graft versus host disease, autoimmune diseases, psoriasis and chronic inflammatory diseases.
    Type: Grant
    Filed: July 6, 1990
    Date of Patent: August 4, 1992
    Assignee: Du Pont Merck Pharmaceutical Company
    Inventors: Carl H. Behrens, Bruce D. Jafee